Clincosm LogoSign in Get a demo

Hepatitis C

Showing NaN - NaN of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in New York (Harvoni (Fixed dose combination ledipasvir/sofosbuvir))

Completed
Has Results
  • Hepatitis C
  • Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
  • New York, New York
    Rockefeller University Hospital
Jul 25, 2019

Care Coordination in Linkage to Care for Hepatitis C Following

Completed
  • Hepatitis C
  • Research transitional care coordination
  • New York, New York
    NYU Langone Health
Jul 29, 2019

Hepatitis C Trial in Puerto Rico, United States

Completed
Has Results
  • Hepatitis C
    • Anaheim, California
    • +12 more
    Dec 12, 2018

    Hepatitis C Trial in Worldwide (SOF/VEL/VOX, Placebo)

    Completed
    Has Results
    • Hepatitis C
    • Long Beach, California
    • +85 more
    Feb 8, 2019

    Hepatitis C Trial in Worldwide (SOF/VEL/VOX, SOF/VEL)

    Completed
    Has Results
    • Hepatitis C
    • Long Beach, California
    • +92 more
    Feb 8, 2019

    Adult-to-Adult Living Donor Transplant Cohort Study

    Completed
    • Liver Diseases
    • +4 more
      • San Francisco, California
      • +8 more
      Feb 7, 2019

      Hepatitis C Trial in Worldwide (SOF, VEL, RBV)

      Completed
      Has Results
      • Hepatitis C
      • Long Beach, California
      • +48 more
      Oct 19, 2018

      Hepatitis C Trial in Puerto Rico, United States (SOF, VEL, RBV)

      Completed
      Has Results
      • Hepatitis C
      • La Jolla, California
      • +50 more
      Oct 19, 2018

      Hepatocellular Carcinoma, HCC, Hepatitis C Trial in New York (Automated reminders, Patient navigation)

      Completed
      • Hepatocellular Carcinoma
      • +3 more
      • Automated reminders
      • Patient navigation
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Oct 10, 2018

      Hepatitis C Trial in La Jolla, New York, Murray (Simeprevir, Sofosbuvir, Ribavirin)

      Completed
      Has Results
      • Hepatitis C
      • La Jolla, California
      • +2 more
      May 21, 2018

      Hepatitis C, Opioid Use Trial in New York (Staying Safe (Ssafe), Healthy Living)

      Unknown status
      • Hepatitis C
      • Opioid Use
      • Staying Safe (Ssafe)
      • Healthy Living
      • New York, New York
        Staying Safe Study 235 Eldridge Street
      May 9, 2018

      HIV-1 Infection, Hepatitis C Trial in San Francisco, New York (Ledipasvir/sofosbuvir, Ribavirin)

      Terminated
      Has Results
      • HIV-1 Infection
      • Hepatitis C
      • San Francisco, California
      • +1 more
      Apr 2, 2018

      Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

      Completed
      • Hepatitis C
      • +2 more
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Jan 16, 2018

        Adult-to-Adult Living Donor Liver Transplantation Study

        Completed
        • Cirrhosis
        • +2 more
          • Los Angeles, California
          • +8 more
          Aug 27, 2017

          Hepatitis C Trial in United States (peginterferon alfa-2a, Ribavirin)

          Completed
          • Hepatitis C
          • San Francisco, California
          • +7 more
          Aug 2, 2017

          Hepatitis C Trial in Worldwide (SOF, RBV, Peg-IFN)

          Completed
          Has Results
          • Hepatitis C
          • Riverside, California
          • +77 more
          May 24, 2017

          Thrombocytopenia, Hepatitis C, HIV Trial in New York (Anti-D)

          Terminated
          Has Results
          • Thrombocytopenia
          • +2 more
          • New York, New York
            New York Presbyterian Hospital (Cornell)
          Apr 14, 2017

          HIV, Hepatitis C, Co-Infection Trial in New York (Prep-C, Educational Control)

          Completed
          • HIV
          • +2 more
          • Prep-C
          • Educational Control
          • New York, New York
            Icahn School of Medicine at Mount Sinai
          May 1, 2017

          Hepatitis C Trial in Worldwide (Ribavirin, Mericitabine, Peginterferon Alfa-2a)

          Completed
          • Hepatitis C
          • Birmingham, Alabama
          • +38 more
          Apr 21, 2017

          Biomarkers of Liver Fibrosis

          Terminated
          • Hepatitis C
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Apr 10, 2017

            Hepatitis C, HIV Trial in Baltimore, New York, Seattle (Peer Mentoring Intervention for HCV-Infected IDUs)

            Completed
            • Hepatitis C
            • HIV Infections
            • Peer Mentoring Intervention for HCV-Infected IDUs
            • Baltimore, Maryland
            • +2 more
            Jan 10, 2017

            Hepatitis C Trial in Worldwide (Alisporivir, Peginterferon alfa-2a, Ribavirin)

            Completed
            Has Results
            • Hepatitis C
            • Beverly Hills, California
            • +146 more
            Aug 5, 2016

            Hepatitis C, Chronic Pain Trial in Worldwide (Alisporivir, Peginterferon alfa-2a, Ribavirin)

            Completed
            Has Results
            • Hepatitis C
            • Chronic Pain
            • La Jolla, California
            • +72 more
            Jul 20, 2016

            Hepatitis C Trial in Worldwide (Alisporivir, Peginterferon alfa-2a, Ribavirin)

            Completed
            Has Results
            • Hepatitis C
            • San Diego, California
            • +74 more
            Jul 14, 2016

            Hepatitis C Trial in Worldwide (Alisporivir, Peginterferon alfa-2a, Ribavirin)

            Terminated
            Has Results
            • Hepatitis C
            • Phoenix, Arizona
            • +59 more
            Jun 30, 2016